Rare Epilepsy Market Lead - New England

Role: The Rare Epilepsy Market Lead is a field-based strategic expert responsible for engaging with epilepsy Centers of Excellence and healthcare providers within the New England territory to promote Onfi (clobazam) and Sabril (vigabatrin). Objectives include advancing disease awareness, supporting patient education, and identifying local market opportunities through stakeholder engagement. Responsibilities encompass developing and executing territory business plans, providing disease state education on Developmental and Epileptic Encephalopathies (DEEs), leveraging insights to inform account strategies, and collaborating across Commercial, Medical, Advocacy, and Market Access teams. The role also involves managing relationships with patient advocacy groups, understanding reimbursement and regulatory frameworks like REMS, and utilizing analytics tools to track activity and outcomes. Potential future responsibilities include managing a field team. Qualifications include a Bachelor’s degree, 7+ years of experience in the pharmaceutical/biotech industry, with at least 3 years in specialty sales, preferably within neurology or rare neurological diseases. Key skills include clinical and business acumen, excellent communication, and cross-functional collaboration. Preferred background features experience with neurology, rare diseases, product launches, REMS programs, and familiarity with academic health systems. The position requires up to 70% domestic travel, with a compensation range of $190,000-$230,000 plus incentives. The role emphasizes compliance, customer engagement, and collaborative teamwork within a complex, high-science environment focused on rare neurological conditions.